Ken Moseley, Senior VP and General Counsel at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 23,500 shares at $20.04 ($472K) on 2016-09-21, disclosed to the SEC on 2016-09-23.
Open-market sale of $472k BLCM by Senior VP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.04 | 100 | $2K | 0.4% |
| 2 | $20.10 | 11,700 | $235K | 49.8% |
| 3 | $20.10 | 11,700 | $235K | 49.8% |
| Total | $20.10 avg | 23,500 | $472K | 100% |
| Filing → |
| BLCM | SELL | 2016-08-17 | $20K | — | Filing → |
| BLCM | SELL | 2016-06-06 | $195K | — | Filing → |
| BLCM | SELL | 2015-11-04 | $195K | — | Filing → |